Shares

9 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

May 15, 2023

SELL
$0.16 - $0.34 $0 - $0
-1 Reduced 0.03%
3,250 $0
Q4 2022

Feb 14, 2023

SELL
$0.22 - $15.3 $110 - $7,665
-501 Reduced 13.35%
3,251 $0
Q3 2022

Nov 14, 2022

SELL
$0.0 - $21.78 $0 - $21,845
-1,003 Reduced 21.09%
3,752 $1,000
Q2 2022

Oct 27, 2022

SELL
$0.0 - $0.0 $0 - $0
-5,489 Reduced 53.58%
4,755 $2,000
Q2 2022

Aug 15, 2022

SELL
$0.0 - $0.0 $0 - $0
-5,489 Reduced 53.58%
4,755 $2,000
Q1 2022

Oct 27, 2022

BUY
$0.0 - $0.0 $0 - $0
5,489 Added 115.44%
10,244 $11,000
Q1 2022

May 13, 2022

SELL
$0.0 - $0.0 $0 - $0
-843 Reduced 7.6%
10,244 $11,000
Q4 2021

Feb 14, 2022

SELL
$0.0 - $6.95 $0 - $192,403
-27,684 Reduced 71.4%
11,087 $12,000
Q3 2021

Nov 15, 2021

BUY
$0.0 - $7.49 $0 - $290,394
38,771 New
38,771 $80,000

Others Institutions Holding YCBD

About cbdMD, Inc.


  • Ticker YCBD
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 60,555,600
  • Market Cap $21.8M
  • Description
  • cbdMD, Inc. produces and distributes various cannabidiol (CBD) products. The company owns and operates consumer hemp-based CBD brands, such as cbdMD, Paw CBD, and cbdMD Botanicals. Its cbdMD brand products include CDB tinctures, gummies, topicals, capsules, bath bombs, bath salts, and sleep aids. It also offers veterinarian-formulated products, ...
More about YCBD
Track This Portfolio

Track Morgan Stanley Portfolio

Follow Morgan Stanley and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Morgan Stanley, based on Form 13F filings with the SEC.

News

Stay updated on Morgan Stanley with notifications on news.